The firm is scrutinizing whether these agreements prioritize insider interests over those of ordinary shareholders or inadvertently stifle superior competing bids. Specifically, the inquiry targets AvalonBay’s all-stock sale to Equity Residential, Open Lending’s $3.15-per-share deal with ANV Group Holdings, Apogee Therapeutics’ $135.11-per-share cash exit to AbbVie, and Taylor Morrison Home Corporation’s $72.50-per-share sale to Berkshire Hathaway.

Attorneys Daniel Sadeh and Zachary Halper intend to pursue increased consideration or enhanced disclosures for investors affected by these mergers. The firm operates on a contingent fee basis, meaning shareholders incur no out-of-pocket costs while seeking potential remedies or corporate reforms. These investigations reflect a broader push by the firm to challenge deal terms that may undervalue equity holdings in high-stakes corporate transitions.